Rivamer 1.5 mg

Each Rivamer 1.5 mg hard capsule contains the active substance Rivastigmine, a prescription treatment for individuals with mild to moderately severe dementia of Alzheimer’s disease. Rivastigmine belongs to a class of drugs known as cholinesterase inhibitors. The drug class work by blocking the normal breakdown of acetylcholine. Those with Alzheimer’s disease have low levels of acetylcholine in the brain. By blocking the action of certain enzymes responsible for the breakdown of acetylcholine, Rivamer allows levels of acetylcholine to increase in the brain. This, in turn, reduces the symptoms of dementia and Alzheimer’s disease associated with Parkinson’s disorder. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition. Alzheimer’s dementia is a progressive brain disorder that gradually affects memory, behaviour, and intellectual ability.